Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BMA
BMA logo

BMA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Banco Macro SA (BMA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
82.860
1 Day change
1.06%
52 Week Range
106.150
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Banco Macro SA (BMA) is not a strong buy for a long-term beginner investor at this time. The lack of positive financial performance, absence of significant trading signals, and neutral trading sentiment suggest that the stock does not currently present an optimal entry point for investment.

Technical Analysis

The stock shows a bullish moving average trend (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (1.262), indicating some upward momentum. However, the RSI at 67.659 is neutral, and the price is near resistance levels (R1: 82.948). The stock's recent price change is -1.23%, and the market is currently closed.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
11

Positive Catalysts

  • The stock has a 70% chance of gaining 5.05% in the next month based on historical candlestick patterns. Bullish moving averages and a positive MACD histogram support a potential upward trend.

Neutral/Negative Catalysts

  • Financial performance in 2025/Q4 shows significant declines in revenue (-4.42% YoY), net income (-38.51% YoY), and EPS (-40.00% YoY). No recent news, no congress trading activity, and neutral trading sentiment from hedge funds and insiders. The RSI indicates no clear signal, and the stock is near resistance levels.

Financial Performance

In 2025/Q4, revenue dropped by -4.42% YoY, net income fell by -38.51% YoY, and EPS declined by -40.00% YoY. This indicates a weak financial performance with no signs of growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available for BMA.

Wall Street analysts forecast BMA stock price to rise
7 Analyst Rating
Wall Street analysts forecast BMA stock price to rise
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 81.990
sliders
Low
74.72
Averages
99.95
High
130
Current: 81.990
sliders
Low
74.72
Averages
99.95
High
130
HSBC
Buy
to
Hold
downgrade
$80
AI Analysis
2025-12-12
Reason
HSBC
Price Target
$80
AI Analysis
2025-12-12
downgrade
Buy
to
Hold
Reason
HSBC downgraded Banco Macro to Hold from Buy with an $80 price target.
UBS
NULL
to
Buy
initiated
$130
2025-11-19
Reason
UBS
Price Target
$130
2025-11-19
initiated
NULL
to
Buy
Reason
UBS initiated coverage of Banco Macro with a Buy rating and $130 price target. The firm believes the Argentine banking sector is at an "inflection point" after years of inflation, tight capital controls, and negative real interest rates. UBS is taking a "somewhat conservative approach" on the group, putting its only Buy rating on Banco Macro due to its better capital position, "resilient" franchise and potentially lower credit quality risk.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BMA
Unlock Now

People Also Watch